Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jae-Cheol Lee

Showing results (201-210 of 226) with videos related to

Pageof 23
Sort By:
Cells|May 13, 2023
Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY TrialCheol-Kyu Park, Ha Ra Jun, Hyung-Joo Oh, et al.
Cancers|February 10, 2024
Real-World Outcomes of Crizotinib in ROS1-Rearranged Advanced Non-Small-Cell Lung CancerHyeon Hwa Kim, Jae Cheol Lee, In-Jae Oh, et al.
Nature Communications|December 5, 2023
Direct identification of interfacial degradation in blue OLEDs using nanoscale chemical depth profilingGustavo F Trindade, Soohwan Sul, Joonghyuk Kim, et al.
Experimental & Molecular Medicine|August 11, 2019
Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancerDong Ha Kim, HyeongRyul Kim, Yun Jung Choi, et al.
Biochemical and Biophysical Research Communications|April 24, 2016
Hippo pathway effector YAP inhibition restores the sensitivity of EGFR-TKI in lung adenocarcinoma having primary or acquired EGFR-TKI resistanceJeong Eun Lee, Hee Sun Park, Dahye Lee, et al.
The Clinical Respiratory Journal|January 5, 2025
Study Protocol of the Korean EGFR Registry: A Multicenter Prospective and Retrospective Cohort Study in Nonsmall Cell Lung Cancer Patients With EGFR MutationChang Dong Yeo, Dong Won Park, Seong Hoon Yoon, et al.
The European Respiratory Journal|January 9, 2025
Inhibition of AXL ameliorates pulmonary fibrosis <i>via</i> attenuation of M2 macrophage polarisationDong Ha Kim, Kyungtaek Im, In-Jeoung Baek, et al.
Biochemical and Biophysical Research Communications|August 1, 2016
The E3 ubiquitin ligase CHIP selectively regulates mutant epidermal growth factor receptor by ubiquitination and degradationChaeuk Chung, Geon Yoo, Tackhoon Kim, et al.
Clinical Lung Cancer|May 23, 2015
Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative ResectionChanghoon Yoo, Shinkyo Yoon, Dae Ho Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|April 23, 2014
RNA sequencing identifies novel markers of non-small cell lung cancerSeon-Sook Han, Woo Jin Kim, Yoonki Hong, et al.
Pageof 23

Showing results (201-210 of 226) with videos related to

Sort By:
Pageof 23
Cells|May 13, 2023
Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY TrialCheol-Kyu Park, Ha Ra Jun, Hyung-Joo Oh, et al.
Cancers|February 10, 2024
Real-World Outcomes of Crizotinib in ROS1-Rearranged Advanced Non-Small-Cell Lung CancerHyeon Hwa Kim, Jae Cheol Lee, In-Jae Oh, et al.
Nature Communications|December 5, 2023
Direct identification of interfacial degradation in blue OLEDs using nanoscale chemical depth profilingGustavo F Trindade, Soohwan Sul, Joonghyuk Kim, et al.
Experimental & Molecular Medicine|August 11, 2019
Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancerDong Ha Kim, HyeongRyul Kim, Yun Jung Choi, et al.
Biochemical and Biophysical Research Communications|April 24, 2016
Hippo pathway effector YAP inhibition restores the sensitivity of EGFR-TKI in lung adenocarcinoma having primary or acquired EGFR-TKI resistanceJeong Eun Lee, Hee Sun Park, Dahye Lee, et al.
The Clinical Respiratory Journal|January 5, 2025
Study Protocol of the Korean EGFR Registry: A Multicenter Prospective and Retrospective Cohort Study in Nonsmall Cell Lung Cancer Patients With EGFR MutationChang Dong Yeo, Dong Won Park, Seong Hoon Yoon, et al.
The European Respiratory Journal|January 9, 2025
Inhibition of AXL ameliorates pulmonary fibrosis <i>via</i> attenuation of M2 macrophage polarisationDong Ha Kim, Kyungtaek Im, In-Jeoung Baek, et al.
Biochemical and Biophysical Research Communications|August 1, 2016
The E3 ubiquitin ligase CHIP selectively regulates mutant epidermal growth factor receptor by ubiquitination and degradationChaeuk Chung, Geon Yoo, Tackhoon Kim, et al.
Clinical Lung Cancer|May 23, 2015
Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative ResectionChanghoon Yoo, Shinkyo Yoon, Dae Ho Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|April 23, 2014
RNA sequencing identifies novel markers of non-small cell lung cancerSeon-Sook Han, Woo Jin Kim, Yoonki Hong, et al.
Pageof 23